Preclinical evaluation of a radionuclide diagnostic probe targeting MUC1

Jin Ding; Dan Wen; Zhong Lin Wang; Jinping Tao; Teli Liu; Dapeng Zhou; Zhi Yang; Hua Zhu

doi:10.1016/j.nucmedbio.2025.109327

Related publications

Article2017

Abstract 32: Preclinical evaluation of MCLA-158: A bispecific antibody targeting LGR5 and EGFR using patient-derived colon carcinoma organoids

Rob C. Roovers, Bram Herpers, Mark I. James, Berina Eppink, Carme Cortina, David Maussang-Detaille, Ingrid Kolfschoten, Sylvia Boy, Marc van de Wetering, Wim de Lau, Robert P. Doornbos, Kuan Yan, Lucia Salinaro, Lex Bakker, John de Kruif, Hans Clevers, Robert G.J. Vries, Eduard Batlle, Leo Price, Mark Throsby

Article2002

Future of radionuclide therapy

Manfred M. Fischer, William H. Becker

International Congress Series

Article2012

Radionuclide Therapy of Bone Metastases

Manfred M. Fischer, Willm Uwe Kampen

Breast Care

Article2002

Radionuclide therapy of inflammatory joint diseases

Manfred M. Fischer, Gynter Mödder

Nuclear Medicine Communications

Letter2016

Radionuclide therapy of malignant bone lesions

Manfred M. Fischer, H. J. Biersack

European Journal of Nuclear Medicine and Molecular Imaging